中国贴牌企业的危机及其出路

中国制造企业尤其是OEM在市场价值链中扮演着低端角色,这种发展模式潜伏着许多危机,不是企业长久发展模式.因此,必须实行OEM企业的转型,走长期的可持续发展之路.     

以人为本是科学发展观的核心

科学发展观是胡锦涛同志为总书记的党中央的重要理论创造。以人为本是科学发展观的核心,同时也自然成为我们党的执政理念。长期以来,偏离以人为本的发展观念和发展实践不乏教训。改革开放以来,特别是近些年来,在发展问题上,也出现一些值得注意的情况。这说明了发展中还存在着目的不明确、偏离以人为本的要求。树立科学发展观,有三个问题需要进一步明确一是正确认识经济社会协调发展与以经济建设为中心的关系,二是正确认识全面、协调发展中包含了适度发展的要求,三是要注意从以人为本的角度全面理解现代化。科学发展观触及到很深层次的问题,要落实它首先是思想解放。     

行政文化转型滞后对于提高执政能力的障碍性

执政党的执政意图和执政目的,在相当程度上要通过政府的行政行为去实现。近年来在行政体制改革进程中所暴露出来的并且得到人们普遍认同的我国传统行政文化转型的滞后性,不仅妨碍行政体制改革的进程,也构成了提升执政党执政能力的障碍。关注和重视这种障碍性,并适时实现政府行政文化创新,极为重要。     

古代中国民本思想长期存在的原因、价值及其揭示的问题

民本思想自形成后便长期存在于古代中国社会.其原因主要是它披上德治主义的合法外衣、匹配重农抑商的合法政策以及与尊君构成失衡的一体两翼关系.民本思想长期存在的主要价值体现为直接价值和根本价值.前者在于它是社会秩序的润滑剂,后者在于它成了人文精神的表演场.它的长期存在还揭示了古代中国一直没有解决好的问题:周期性存在的民生问题、无法摆脱的农民造反和治乱循环之周期律、难以实现社会的持续性发展以及王朝体制存在诸多制约社会发展的弊端.     

Voting when the economy goes bad,everyone is in charge,and no one is to blame: The case of the 2009 German election

The economy was a major issue in Germany’s 2009 election. The global economic crisis did not spare Germany, whose economy is tightly integrated into the global economy. So when the German economy experienced a historical shock, did voters connect their views of the economy with their vote choice? Or did they, as some research has suggested, recognize Germany’s dependence on global markets and cut the government slack, especially when the government consists of the country’s two major parties? Using pre- and post-election panel surveys from the German Longitudinal Election Study (GLES), we investigate the weight that voters gave to the economy, relative to other considerations, when casting their ballot and whether governing parties were disproportionately judged based on the state of the economy.     

The ratio of vision to data: Promoting emergent science and technologies through promissory regulation,the case of the FDA and personalised medicine

Pharmacogenetic tests provide genetic data to tailor drug treatment and were widely predicted to be one of the first fruits of the Human Genome Project. In the mid-2000s, the US Food and Drugs Administration (FDA) became an advocate for pharmacogenetic testing, but its efforts to build a market for this new technology brought the agency into dispute with other regulatory actors over the type of evidence needed for the adoption of pharmacogenetic testing, in particular the importance of randomized control trials. The warfarin case highlights the tension between a new form of promissory regulation driven by future expectations and FDA's established role as protector of public health; and the controversy can be conceptualized as a struggle over regulatory epistemologies within a complex polycentric regulatory space. Our case study addresses two themes central to the burgeoning scholarship on the governance of emergent science and technologies (EST): the political economy of regulation, in particular the role that regulators play in creating markets for EST; and the epistemological politics of regulatory science, in particular the controversy that arises when regulators modify scientific standards to accommodate EST. Linking these two themes is the concept of promissory regulation: the idea that regulatory policy may be shaped by an institutional commitment to the transformational potential of EST. This concept sheds new light on the neo-mercantilist nature of contemporary regulatory capitalism.